Association Between PD-L1 Expression and c-Met Alterations in Non-Small Cell Lung Carcinoma

被引：0
|
作者：
Tenney, Troy [1 ]
Sica, Gabriel [2 ]
Saxe, Debra [3 ]
Owonikoko, Taofeek [3 ]
Ramalingam, Suresh [3 ]
Zhang, Linsheng [2 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Atlanta, GA USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1961
引用
收藏
页码：1821 / 1821
页数：1
相关论文
共 50 条
  • [41] The metastatic site does not influence PD-L1 expression in advanced non-small cell lung carcinoma
    Wang, H.
    Agulnik, J.
    Kasymjanova, G.
    Fiset, P. O.
    Camilleri-Broet, S.
    Redpath, M.
    Cohen, V
    Small, D.
    Pepe, C.
    Sakr, L.
    Spatz, A.
    LUNG CANCER, 2019, 132 : 36 - 38
  • [42] PD-L1 immunohistochemistry for non-small cell lung carcinoma: concordance between cytology and histology specimens
    van Haeringen, B.
    Gupta, S.
    Godbolt, D.
    Skerman, J.
    Cooper, C.
    HISTOPATHOLOGY, 2022, 81 : 169 - 169
  • [43] Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma (ccRCC) and its association with PD-L1 expression.
    Lalani, Aly-Khan A.
    Albiges, Laurence
    Gray, Kathryn P.
    Pal, Soumitro
    Pignon, Jean-Christophe
    Gupta, Mamta
    Bhatt, Rupal Satish
    McDermott, David F.
    Atkins, Michael B.
    Woude, George Franklin Vande
    Signoretti, Sabina
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [44] Non-Small Cell Lung Cancer, PD-L1, and the Pathologist
    Kerr, Keith M.
    Nicolson, Marianne C.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (03) : 249 - 254
  • [45] Expression and clinical significance of PD-L1 and c-Myc in non-small cell lung cancer
    Cuiling Zhou
    Gang Che
    Xiaobin Zheng
    Junlan Qiu
    Zhinan Xie
    Yunyan Cong
    Xiaofeng Pei
    Hongyu Zhang
    Huanhuan Sun
    Haiqing Ma
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 2663 - 2674
  • [46] c-Met Amplification and Protein Expression in Non-Small Cell Lung Cancers.
    Tsuta, K.
    Yoshida, A.
    Tsuda, H.
    MODERN PATHOLOGY, 2011, 24 : 426A - 426A
  • [47] Expression and clinical significance of PD-L1 and c-Myc in non-small cell lung cancer
    Zhou, Cuiling
    Che, Gang
    Zheng, Xiaobin
    Qiu, Junlan
    Xie, Zhinan
    Cong, Yunyan
    Pei, Xiaofeng
    Zhang, Hongyu
    Sun, Huanhuan
    Ma, Haiqing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (11) : 2663 - 2674
  • [48] PD-L1 Expression in Adenosquamous Lung Carcinoma and the Comparison with the Other Common Variants of Non-Small Cell Lung Cancer
    Shi, Xiaohua
    Wu, Shafei
    Sun, Jian
    Liu, Yuanyuan
    Zeng, Xuan
    Liang, Zhiyong
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S989 - S989
  • [49] Recent updates regarding PD-L1 testing in non-small cell lung carcinoma
    Adam, Julien
    Forest, Fabien
    Mansuet-Lupo, Audrey
    Ilie, Marius
    Antoine, Martine
    Begueret, Hugues
    Cazes, Aurelie
    Badoual, Cecile
    Cote, Jean-Francois
    Damotte, Diane
    Penault-Llorca, Frederique
    Garcia, Stephane
    Gibault, Laure
    Hofman, Paul
    Hofman, Veronique
    Lantuejoul, Sylvie
    Rouquette, Isabelle
    Vignaud, Jean-Michel
    ANNALES DE PATHOLOGIE, 2019, 39 (04) : 303 - 304
  • [50] Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer
    Dori, Shani Ben
    Aizic, Asaf
    Sabo, Edmond
    Hershkovitz, Dov
    LUNG CANCER, 2020, 147 : 91 - 98
12345